Skip to main content

Press release · EX-71332

Allergic Rhinoconjunctivitis Market Expanding Immunotherapy Adoption, OTC Growth, and Forecast Outlook 2025–2035

Allergic Rhinoconjunctivitis (ARC) is a common allergic condition characterized by inflammation of the nasal passages and conjunctiva due to exposure to allergens such as pollen, dust mites, mold, and pet dander. Symptoms include sneezing, nasal congestion, itchy eyes, watery di…

Published Feb 12, 2026 Author Admin Desk Healthcare Read 2 min

Allergic Rhinoconjunctivitis (ARC) is a common allergic condition characterized by inflammation of the nasal passages and conjunctiva due to exposure to allergens such as pollen, dust mites, mold, and pet dander. Symptoms include sneezing, nasal congestion, itchy eyes, watery discharge, and redness. The increasing prevalence of allergic diseases, urbanization, and environmental pollution are key factors driving growth in the global Allergic Rhinoconjunctivitis market.

 

Market Size and Growth

  • The global Allergic Rhinoconjunctivitis market was valued at approximately USD 8–10 billion in 2024.
  • The market is projected to grow at a CAGR of 5–7% between 2025 and 2035.
  • By 2035, the market is expected to reach USD 14–18 billion, supported by rising allergy prevalence and expanding immunotherapy adoption.
  • Growth is driven by increasing over-the-counter (OTC) product availability and advancements in targeted allergy treatments.

 

Key Market Drivers

1. Rising Prevalence of Allergic Disorders

Growing environmental pollution, climate change, and urban lifestyles have contributed to increasing allergy incidence worldwide.

2. Expanding Immunotherapy Adoption

Allergen-specific immunotherapy (subcutaneous and sublingual) is gaining popularity as a long-term disease-modifying approach.

3. OTC Market Expansion

Widespread availability of antihistamines, nasal sprays, and eye drops without prescription boosts market revenue.

4. Technological and Diagnostic Advancements

Improved allergy testing methods and digital health tools are supporting earlier and more accurate diagnosis.

 

Treatment Landscape

The Allergic Rhinoconjunctivitis market includes:

  • Antihistamines – Oral and topical formulations widely used for symptom control.
  • Intranasal Corticosteroids – Considered first-line therapy for moderate-to-severe cases.
  • Mast Cell Stabilizers – Used for prevention of allergic reactions.
  • Leukotriene Receptor Antagonists – Adjunct therapy in certain patients.
  • Allergen Immunotherapy – Subcutaneous and sublingual therapies offering long-term relief.
  • Combination Therapies – Products combining antihistamines and corticosteroids for improved efficacy.

 

Regional Insights

North America

  • Largest market share due to high allergy prevalence and strong OTC product sales.
  • Advanced healthcare infrastructure and high awareness levels drive demand.

Europe

  • Significant adoption of immunotherapy, particularly sublingual treatments.
  • Increasing focus on long-term allergy management strategies.

Asia-Pacific

  • Fastest-growing region driven by urbanization, pollution, and improving healthcare access.
  • Expanding middle-class population supports OTC and prescription product growth.

 

Competitive Landscape

Key companies operating in the Allergic Rhinoconjunctivitis market include:

  • GlaxoSmithKline
  • Sanofi
  • Johnson & Johnson
  • Bayer
  • Stallergenes Greer
  • ALK-Abelló

Competition centers on product differentiation, combination therapies, OTC expansion, and immunotherapy innovation.

 

Market Opportunities

  • Development of long-acting and combination nasal sprays.
  • Expansion of allergen immunotherapy in emerging markets.
  • Digital allergy management platforms.
  • Personalized allergy treatment solutions.

 

Market Challenges

  • Intense competition from generic and OTC products.
  • Seasonal demand fluctuations.
  • Adherence issues with long-term immunotherapy.
  • Regulatory requirements for new biologic therapies.

 

ABOUT EXACTITUDE CONSULTANCY
Exactitude Consultancy is a global market research and consulting firm providing precise forecasts, competitive intelligence, and actionable insights across healthcare, life sciences, and advanced technology domains.Media Contact: Irfan Tamboli | Business Development Executive
📩irfan@amelioratesolutions.com | 🌐 www.exactitudeconsultancy.com

Media enquiries

Covering this release? Reach the analyst who wrote it.

Data extracts, executive quotes and pre-release embargo access for accredited business media. Response within one business day.